ASSESS THE NON-INFERIORITY OF GSK BIOLOGICALS' MENCEVAX™ ACWY (MANUFACTURED BY A NEW PROCESS) VS MENCEVAX™ ACWY (THE ALREADY EXISTING VACCINE IN THE MARKET) WHEN GIVEN AS A SINGLE DOSE TO SUBJECTS AGED 2-30 YRS: